“Impact of Sars-CoV-2 Prophylaxis With Tixagevimab-Cilgavimab in High-Risk Patients With B-Cell Malignancies: A Single-Center Retrospective Study”. 2023. Mediterranean Journal of Hematology and Infectious Diseases 15 (1): e2023061. https://doi.org/10.4084/MJHID.2023.061.